ELAB

NASDAQ Healthcare

PMGC Holdings Inc. - Common Stock

Biotechnology

PMGC Holdings Inc., a biopharmaceutical company, focuses on the development and acquisition of cutting-edge aesthetic medicines and therapeutic products. The company's lead product includes EL-22, a first-in-class engineered probiotic approach to address obesity's pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists. It is also involved in the medical scientific research and development activities, as well as operates investment firms. The company was formerly known as Elevai Labs, Inc. and changed its name to PMGC Holdings Inc. in December 2024. PMGC Holdings Inc. was incorporated in 2020 and is based in Newport Beach, California.

�� 市场数据

价格	$3.28
成交量	10,475,294
市值	6.35M
贝塔系数	0.710
RSI（14日）	53.0
200日均线	$92.64
50日均线	$5.80
52周最高	$309.89
52周最低	$1.62
Price / Book	0.03